Medicare Enrolled
Dr. Susmitha Apuri, M.D
Hematology · Inverness, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Apuri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Apuri? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Apuri
Dr. Susmitha Apuri is a hematology in Inverness, FL, with 17 years in practice. Based on federal Medicare data, Dr. Apuri performed 219,278 Medicare services across 5,245 unique beneficiaries.
Between the years covered by Open Payments, Dr. Apuri received a total of $16,750 from 88 pharmaceutical and/or device companies across 688 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Apuri is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 18% volume in FL$ $16,750 industry payments
Medicare Practice Summary
Medicare Utilization ↗219,278
Medicare services
Top 18% in FL for hematology
5,245
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12,899 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 65,790 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 20,200 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 18,330 | $1 | $5 |
| Iron infusion (Injectafer) | 18,000 | $1 | $3 |
| Filgrastim injection (Zarxio) for white blood cells | 18,000 | $0 | $2 |
| Paclitaxel chemotherapy injection | 15,055 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 11,270 | $6 | $23 |
| Filgrastim injection (Nivestym) for white blood cells | 11,160 | $0 | $1 |
| Nivolumab injection (Opdivo) | 9,043 | $24 | $72 |
| Denosumab injection (Prolia/Xgeva) | 8,280 | $19 | $51 |
| Immune globulin infusion (Gammagard) | 4,636 | $36 | $108 |
| Complete blood count (CBC) with differential | 3,002 | $8 | $29 |
| Blood draw (venipuncture) | 2,980 | $8 | $9 |
| Dexamethasone injection (steroid) | 2,862 | $0 | $3 |
| Office visit, established patient (30-39 min) | 1,703 | $95 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,660 | $1 | $28 |
| Drug injection, under skin or into muscle | 897 | $11 | $69 |
| Office visit, established patient (20-29 min) | 672 | $65 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 592 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 591 | $98 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 582 | $22 | $84 |
| Injection, carboplatin, 50 mg | 537 | $2 | $41 |
| Injection of additional new drug or substance into vein | 450 | $12 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 411 | $47 | $189 |
| Injection, zoledronic acid, 1 mg | 297 | $7 | $69 |
| Administration of chemotherapy into vein, each additional hour | 294 | $21 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 263 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 185 | $15 | $56 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 170 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 163 | $49 | $178 |
| New patient office visit (45-59 min) | 147 | $119 | $453 |
| Injection, fluorouracil, 500 mg | 114 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 111 | $24 | $156 |
| Infusion, normal saline solution , 1000 cc | 104 | $2 | $7 |
| Infusion into a vein for hydration, each additional hour | 97 | $10 | $42 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 91 | $17 | $59 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 72 | $1 | $7 |
| Prothrombin time test (blood clotting) | 62 | $4 | $15 |
| New patient office visit, complex (60-74 min) | 51 | $157 | $585 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 47 | $3 | $11 |
| Administration of additional new drug or substance into vein using push technique | 46 | $42 | $170 |
| Automated urinalysis | 41 | $2 | $8 |
| Initial hospital admission, high complexity | 37 | $137 | $556 |
| Injection of drug or substance into vein | 36 | $27 | $156 |
| Office visit, established patient, complex (40-54 min) | 32 | $127 | $474 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 29 | $135 | $467 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 29 | $26 | $89 |
| Hospital follow-up visit, high complexity | 28 | $94 | $285 |
| Drawing of blood for a medical problem | 17 | $56 | $277 |
| Red blood count, automated test | 12 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.0% high complexity
54.8% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,750
Total received (2018-2024)
Avg $2,393/year across 7 years
Top 29% in FL for hematology
88
Companies
688
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,203 (78.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,260 (19.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$287 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,783
2023$1,820
2022$1,501
2021$1,215
2020$1,774
2019$2,553
2018$5,102
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer HealthCare Pharmaceuticals Inc.
$3,513
Novartis Pharmaceuticals Corporation
$1,222
E.R. Squibb & Sons, L.L.C.
$767
AstraZeneca Pharmaceuticals LP
$724
Celgene Corporation
$716
Janssen Biotech, Inc.
$691
PFIZER INC.
$494
Lilly USA, LLC
$465
Merck Sharp & Dohme LLC
$456
Genentech USA, Inc.
$456
Amgen Inc.
$447
Incyte Corporation
$394
Merck Sharp & Dohme Corporation
$387
GENZYME CORPORATION
$375
Gilead Sciences, Inc.
$373
Octapharma USA, Inc.
$272
EMD Serono, Inc.
$270
Foundation Medicine, Inc.
$267
Bayer Healthcare Pharmaceuticals Inc.
$259
Eisai Inc.
$248
Daiichi Sankyo Inc.
$246
Astellas Pharma US Inc
$206
PUMA BIOTECHNOLOGY, INC.
$195
GlaxoSmithKline, LLC.
$194
Seattle Genetics, Inc.
$191
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
Seagen Inc.
$189
JAZZ PHARMACEUTICALS INC.
$136
Alexion Pharmaceuticals, Inc.
$126
EISAI INC.
$108
Mirati Therapeutics, Inc.
$107
Karyopharm Therapeutics Inc.
$100
Puma Biotechnology, Inc.
$94
Kite Pharma, Inc.
$93
Agios Pharmaceuticals, Inc.
$92
BeiGene USA, Inc.
$83
ABBVIE INC.
$73
Pharmacyclics LLC, An AbbVie Company
$69
Janssen Products, LP
$65
Rigel Pharmaceuticals, Inc.
$61
INSYS Therapeutics Inc
$51
Taiho Oncology, Inc.
$50
TerSera Therapeutics LLC
$49
AMAG Pharmaceuticals, Inc.
$47
Regeneron Healthcare Solutions, Inc.
$45
Exelixis Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$43
AVEO Pharmaceuticals, Inc.
$42
Myriad Genetic Laboratories, Inc.
$41
Tempus AI, Inc
$36
G1 Therapeutics, Inc.
$36
Array BioPharma Inc.
$36
SOBI, INC
$36
Clovis Oncology, Inc.
$35
ARRAY BIOPHARMA INC
$33
TAIHO ONCOLOGY, INC.
$33
Helsinn Therapeutics (U.S.), Inc.
$30
Lexicon Pharmaceuticals, Inc.
$30
Ipsen Biopharmaceuticals, Inc
$28
Blueprint Medicines Corporation
$27
Janssen Pharmaceuticals, Inc
$26
Heron Therapeutics, Inc.
$25
Aurobindo Pharma USA, Inc.
$25
Aveo Pharmaceuticals, Inc.
$25
Servier Pharmaceuticals LLC
$24
Sun Pharmaceutical Industries Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
Fennec Pharmaceuticals, Inc.
$23
Secura Bio, Inc.
$23
Legend Biotech USA Inc.
$23
Sysmex Inostics Inc
$23
TESARO, Inc.
$22
CSL Behring
$21
Epizyme, Inc.,
$20
EKOS Corporation
$20
Mylan Institutional Inc.
$20
AbbVie Inc.
$18
Pharmacosmos Therapeutics Inc.
$18
MEDIVATION FIELD SOLUTIONS LLC
$18
Collegium Pharmaceutical, Inc.
$18
Dendreon Pharmaceuticals LLC
$18
Sobi, Inc
$17
Partner Therapeutics, Inc.
$16
Verastem, Inc.
$16
ADC Therapeutics America, Inc.
$16
NOVARTIS PHARMACEUTICALS CORPORATION
$15
Acrotech Biopharma Inc.
$14
AbbVie, Inc.
$12
Top 3 companies account for 32.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALOXI · AYVAKIT · Afstyla · Aliqopa · Avastin · BELEODAQ · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CUTAQUIG · CYRAMZA · Cabometyx · Cinvanti · Copiktra · DARZALEX · DOPTELET · EKOSONIC · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · Fabhalta · Farydak · Fulphila · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MVASI · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · PADCEV · PIQRAY · PLUVICTO · POLIVY · PRECISETUMOR · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · Prolia · REBLOZYL · RYBREVANT · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · WELIREG · XALKORI · XARELTO · XPOVIO · XT CDX · XTAMPZAER · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
8
Per 100K population
5.0
County median income
$55,355
Nearest hospital
HCA FLORIDA CITRUS HOSPITAL
9.7 mi
9.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Apuri is a mixed practice specialist, with above-average Medicare volume (top 18% in FL), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Apuri experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Apuri performed 65,790 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Apuri receive payments from pharmaceutical companies?
Yes. Dr. Apuri received a total of $16,750 from 88 companies across 688 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Apuri's costs compare to other hematologys in Inverness?
Dr. Apuri's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Apuri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Inverness
Browse hematologys in Inverness ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology